Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24255544 | 0.96 | ALDH1A1 (0.31) | ALDH1A1HPGD | |
| SCHEMBL26313085 | 0.90 | KDM4E (0.31) | KDM4ELMNASMN1; SMN2 | |
| SCHEMBL24255550 | 0.85 | L3MBTL1 (0.36) | ALDH1A1KDM4ELMNAGAAL3MBTL1 | |
| SCHEMBL24256958 | 0.85 | KDM4E (0.33) | ALDH1A1KDM4ELMNAGAAL3MBTL1 | |
| SCHEMBL20864642 | 0.83 | — | — | |
| SCHEMBL24256807 | 0.83 | L3MBTL1 (0.32) | ALDH1A1KDM4ELMNAGAAL3MBTL1 | |
| SCHEMBL24255540 | 0.83 | MAPT (0.35) | ALDH1A1KDM4ELMNAGAAHPGD | |
| SCHEMBL26313076 | 0.82 | KDM4E (0.32) | ALDH1A1KDM4ELMNAGAAL3MBTL1 | |
| SCHEMBL20864644 | 0.81 | MEN1 (0.31) | — | |
| SCHEMBL26313095 | 0.81 | MEN1 (0.36) | ALDH1A1KDM4ELMNAGAAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230292599-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE | LT MATERIALS CO.,LTD. (KR) | 2023-09-14 | — | — | US | disclosed |
| US-20230292599-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE | LT MATERIALS CO.,LTD. (KR) | 2023-09-14 | — | — | US | disclosed |
| EP-4201930-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE | LT Materials Co., Ltd. (KR) | 2023-06-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230292599-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE | CRY1, PPOX, ORC3 | ALDH1A1 412/4885KDM4E 2416/4885LMNA 604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.